Author Interviews, Cannabis, Hepatitis - Liver Disease / 06.03.2026
Hebrew University Study Finds MASLD, a Common Chronic Liver Disorder, May Benefit from Cannabis Derivatives
Editor’ note: Cannabis and THCA/HEMP CBD products should have an active ingredient list on the container and have a Certificate of Analysis (COA). Discuss your use of THC, Cannabis or CBD products with your health care provider. Dosing of Cannabis products is variable, especially since they are not FDA regulated. Cannabis/CBD may interfere with other medications and should not be used in individuals with certain health conditions, including liver issues. CBD skin care products can be absorbed through the skin and have similar effects. Do not use Cannabis products including edibles, drinks and CBD if you are pregnant, nursing or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery. Children should not be exposed to cannabis or CBD products.
MedicalResearch.com Interview with:
Prof. Joseph (Yossi) Tam, DMD, PhDSchool of Pharmacy, Institute for Drug Research
The Hebrew University of Jerusalem
The Harvey M. Krueger Family Center for Nanoscience and Nanotechnology
Jerusalem, Israel
With colleagues Dr. Liad Hinden, the PhD student Radka Kočvarová, and the Tam’s team at the
School of Pharmacy at the Faculty of Medicine of the Hebrew University of Jerusalem.
MedicalResearch.com: What is the background for this study? Would you describe the condition of Metabolic dysfunction-associated steatotic liver disease (MASLD)? What causes it? Whom does it affect?
Response: MASLD, formerly known as nonalcoholic fatty liver disease (NAFLD), is the most common chronic liver disorder worldwide. It develops when fat accumulates excessively in liver cells, commonly in people with obesity, insulin resistance, high cholesterol, or diabetes. Over time, this condition can progress to inflammation, fibrosis, or cirrhosis. Despite its growing prevalence, effective pharmacological therapies remain limited, leaving a substantial unmet clinical need.
Prof. Joseph (Yossi) Tam, DMD, PhDSchool of Pharmacy, Institute for Drug Research
The Hebrew University of Jerusalem
The Harvey M. Krueger Family Center for Nanoscience and Nanotechnology
Jerusalem, Israel
With colleagues Dr. Liad Hinden, the PhD student Radka Kočvarová, and the Tam’s team at the
School of Pharmacy at the Faculty of Medicine of the Hebrew University of Jerusalem.
MedicalResearch.com: What is the background for this study? Would you describe the condition of Metabolic dysfunction-associated steatotic liver disease (MASLD)? What causes it? Whom does it affect?
Response: MASLD, formerly known as nonalcoholic fatty liver disease (NAFLD), is the most common chronic liver disorder worldwide. It develops when fat accumulates excessively in liver cells, commonly in people with obesity, insulin resistance, high cholesterol, or diabetes. Over time, this condition can progress to inflammation, fibrosis, or cirrhosis. Despite its growing prevalence, effective pharmacological therapies remain limited, leaving a substantial unmet clinical need.
Candida auris CDC Image[/caption]
MedicalResearch.com Interview with:
[caption id="attachment_72627" align="alignleft" width="200"]
Prof. Moo-Yong Rhee[/caption]
Professor Moo-Yong Rhee MD, PhD.
Cardiology,
Dr. Schaffner[/caption]
William Schaffner, MD
MedicalResearch.com: What roles do a decrease in US immunization rates and/or increased immigration from under-vaccinated area play in this increase?
Response: The substantial majority of unimmunized children in the US were born and raised in this country. They usually are members of middle- or upper-income families. The most frequent importers of measles into the US are our own unimmunized children who travel abroad, encounter measles virus and bring it back to their homes where the virus then spreads among the child’s schoolmates and playmates, creating an outbreak.
Dr. Freedman M.D.[/caption]
David O. Freedman, M.D.
Professor Emeritus of Infectious Diseases
Editor of the Textbook of Travel Medicine
World Health Organization—Member, Emergency Committee on Zika Virus
University of Alabama, Birmingham USA
MedicalResearch.com: What is the background for this outbreak?
Response: India has reported 2 confirmed (PCR and ELISA) Nipah virus (NiV) cases in West Bengal State where the Kolkata megalopolis is located; the state borders Bangladesh. Symptom onset in both cases was late December 2025 in 2 health care workers. One patient has improved while the other remains in the ICU. All samples from 200 contact persons tested negative for NiV. No further confirmed cases have been detected in West Bengal
Bangladesh has reported 1 confirmed NiV case in Rajshahi Division which neighbors India. Symptom onset was January 21, 2026, and the patient expired on January 28. The patient reported no travel history but reported repeated consumption of raw date palm sap between 5 and 20 January. All 35 contact-persons are being monitored and have tested negative for NiV and no further cases have been detected to date.
Dr. Kruger[/caption]
MedicalResearch.com: What is the background for this study?
[caption id="attachment_72137" align="alignleft" width="100"]
Dr. Felicione[/caption]
Response: Alcohol consumption, especially heavy alcohol consumption, is associated with many health risks and nearly 200 different health conditions and diseases. Reducing alcohol consumption reduces the risks and harms from alcohol. Previous research has demonstrated that people have reduced their alcohol consumption when they have access to cannabis. Cannabis beverages have emerged in States where cannabis is legal for adult or medical use.
